Literature DB >> 26843665

Overcoming Barriers to Low HPV Vaccine Uptake in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015.

.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26843665      PMCID： PMC4716467          DOI： 10.1177/003335491613100106

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0033-3549            Impact factor:   2.792


× No keyword cloud information.
  19 in total

1.  Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Task Force on Community Preventive Services.

Authors: 
Journal:  Am J Prev Med       Date:  2000-01       Impact factor: 5.043

2.  Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.

Authors:  Diane M Harper; Eduardo L Franco; Cosette M Wheeler; Anna-Barbara Moscicki; Barbara Romanowski; Cecilia M Roteli-Martins; David Jenkins; Anne Schuind; Sue Ann Costa Clemens; Gary Dubin
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

3.  The medical home.

Authors: 
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

Review 4.  Promising alternative settings for HPV vaccination of US adolescents.

Authors:  Parth D Shah; Melissa B Gilkey; Jessica K Pepper; Sami L Gottlieb; Noel T Brewer
Journal:  Expert Rev Vaccines       Date:  2014-01-03       Impact factor: 5.217

5.  Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months.

Authors:  Eduardo Lazcano-Ponce; Margaret Stanley; Nubia Muñoz; Leticia Torres; Aurelio Cruz-Valdez; Jorge Salmerón; Rosalba Rojas; Rolando Herrero; Mauricio Hernández-Ávila
Journal:  Vaccine       Date:  2013-12-16       Impact factor: 3.641

6.  Physicians' human papillomavirus vaccine recommendations, 2009 and 2011.

Authors:  Susan T Vadaparampil; Teri L Malo; Jessica A Kahn; Daniel A Salmon; Ji-Hyun Lee; Gwendolyn P Quinn; Richard G Roetzheim; Karen L Bruder; Tina M Proveaux; Xiuhua Zhao; Neal A Halsey; Anna R Giuliano
Journal:  Am J Prev Med       Date:  2014-01       Impact factor: 5.043

7.  Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

Authors:  Simon R M Dobson; Shelly McNeil; Marc Dionne; Meena Dawar; Gina Ogilvie; Mel Krajden; Chantal Sauvageau; David W Scheifele; Tobias R Kollmann; Scott A Halperin; Joanne M Langley; Julie A Bettinger; Joel Singer; Deborah Money; Dianne Miller; Monika Naus; Fawziah Marra; Eric Young
Journal:  JAMA       Date:  2013-05-01       Impact factor: 56.272

Review 8.  Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.

Authors:  Dawn M Holman; Vicki Benard; Katherine B Roland; Meg Watson; Nicole Liddon; Shannon Stokley
Journal:  JAMA Pediatr       Date:  2014-01       Impact factor: 16.193

9.  Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: results from a randomized study.

Authors:  Barbara Romanowski; Tino F Schwarz; Linda M Ferguson; Murdo Ferguson; Klaus Peters; Marc Dionne; Karin Schulze; Brian Ramjattan; Peter Hillemanns; Ulrich Behre; Pemmaraju Suryakiran; Florence Thomas; Frank Struyf
Journal:  Hum Vaccin Immunother       Date:  2014-02-27       Impact factor: 3.452

10.  Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.

Authors:  Shannon Stokley; Jenny Jeyarajah; David Yankey; Maria Cano; Julianne Gee; Jill Roark; Robinette C Curtis; Lauri Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-07-25       Impact factor: 17.586
View more
  22 in total

1.  The perspectives, barriers, and willingness of Utah dentists to engage in human papillomavirus (HPV) vaccine practices.

Authors:  Katherine L Harris; D Tay; D Kaiser; A Praag; H Rutkoski; B L Dixon; L M Pinzon; J R Winkler; D Kepka
Journal:  Hum Vaccin Immunother       Date:  2019-10-04       Impact factor: 3.452

2.  Evaluation of the 2010 National Vaccine Plan Mid-course Review: Recommendations From the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on February 7, 2017.

Authors: 
Journal:  Public Health Rep       Date:  2017-06-23       Impact factor: 2.792

3.  A multi-site case study of community-clinical linkages for promoting HPV vaccination.

Authors:  Heather M Brandt; Robin C Vanderpool; Susan J Curry; Paige Farris; Jason Daniel-Ulloa; Laura Seegmiller; Lindsay R Stradtman; Thuy Vu; Victoria Taylor; Maria Zubizarreta
Journal:  Hum Vaccin Immunother       Date:  2019-06-03       Impact factor: 3.452

4.  Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states.

Authors:  William A Calo; Parth D Shah; Melissa B Gilkey; Robin C Vanderpool; Sarah Barden; William R Doucette; Noel T Brewer
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

5.  Are state laws granting pharmacists authority to vaccinate associated with HPV vaccination rates among adolescents?

Authors:  Justin G Trogdon; Paul R Shafer; Parth D Shah; William A Calo
Journal:  Vaccine       Date:  2016-08-03       Impact factor: 3.641

6.  Strengthening the Effectiveness of National, State, and Local Efforts to Improve HPV Vaccination Coverage in the United States: Recommendations From the National Vaccine Advisory Committee.

Authors: 
Journal:  Public Health Rep       Date:  2018-08-09       Impact factor: 2.792

7.  Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.

Authors:  Eric Adjei Boakye; Daphne Lew; Meera Muthukrishnan; Betelihem B Tobo; Rebecca L Rohde; Mark A Varvares; Nosayaba Osazuwa-Peters
Journal:  Hum Vaccin Immunother       Date:  2018-06-01       Impact factor: 3.452

8.  Perceived Barriers and Trends in HPV Vaccination via Patient Survey Responses at Kalamazoo, Michigan's Federally-Qualified Health Center.

Authors:  Nathan VanderVeen; Arika Wieneke; Samantha Tran; Amie Kim; Kathryn Davis; Debra Taubel
Journal:  J Community Health       Date:  2020-02

9.  Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.

Authors:  Dana Whittemore; Lili Ding; Lea E Widdice; Darron A Brown; David I Bernstein; Eduardo L Franco; Jessica A Kahn
Journal:  J Womens Health (Larchmt)       Date:  2016-10-18       Impact factor: 2.681

10.  Parents' willingness to get human papillomavirus vaccination for their adolescent children at a pharmacy.

Authors:  William A Calo; Melissa B Gilkey; Parth Shah; Macary W Marciniak; Noel T Brewer
Journal:  Prev Med       Date:  2017-02-07       Impact factor: 4.018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.